Clearance Kinetics
Clearance Kinetics - Related Videos
07:24
A Split-Luciferase Complementation Assay for Temporally Resolved Measurement of Tau Clearance in Microglia
0 Views •
2026
We describe a sensitive, time-resolved quantitative platform to measure clearance of extracellular tau in human induced pluripotent stem cell (iPSC)-derived microglia using a microplate-based luminescence system. This approach enables sensitive detection of tau degradation kinetics in a microwell format, allowing for high-throughput interrogation of tau handling under various experimental conditions.
01:09
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
0 Views •
2025
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance. Most drugs undergo restrictive clearance, which is proportional to the...
03:07
Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy
0 Views •
2020
The kinetic molecular theory qualitatively explains the behaviors described by the various gas laws. The postulates of this theory may be applied in a more quantitative fashion to derive these individual laws. Collectively, the molecules in a sample of gas have average kinetic energy and average speed; but individually, they move at different speeds. Molecules frequently undergo elastic collisions in which the momentum is conserved. Since the colliding molecules are deflected off at different...
08:07
Enzyme Assays and Kinetics
0 Views •
2023
Enzyme kinetics describes the catalytic effects of enzymes, which are biomolecules that facilitate chemical reactions necessary for living organisms. Enzymes act on molecules, referred to as substrates, to form products. Enzyme kinetic parameters are determined via assays that directly or indirectly measure changes in substrate or product concentration over time. This video will cover the basic principles of enzyme kinetics (including rate equations) and kinetic models. The concepts governing...
01:33
Investigating Autophagy-Mediated Clearance of Intracellular Bacteria In Vitro
0 Views •
2026
Take pig kidney cell cultures, with one culture pre-treated with an inhibitor that increases lysosomal pH, impairing autophagic-lysosomal degradation.Add pathogenic bacteria and centrifuge to enhance host-pathogen contact.Incubate to allow bacterial invasion and internalization into endocytic vesicles.The internalized bacteria consume host nutrients to replicate, triggering metabolic stress.This stress activates autophagy, where an autophagic membrane expands around the vesicle, forming an...
FAQs
First-order elimination removes a constant fraction of the substance during each unit of time, so the amount removed changes as the circulating concentration changes. Capacity-limited pathways behave differently once metabolic or transport systems become saturated; removal can then show zero-order behavior, with a more constant amount eliminated per unit time. This distinction affects how concentrations decline and how dosing is planned.
Clearance describes removal, but it does not by itself explain how long a substance remains distributed in the body. Volume of distribution and half-life add complementary information about concentration persistence. Considering all three measures helps clinicians connect observed concentration changes with dose selection, anticipate accumulation, and distinguish a rapid removal process from a prolonged decline in circulating levels.
When hepatic metabolism or transport processes reach capacity, increasing the substance concentration may not increase removal proportionally. The pathway can shift from fraction-based first-order behavior toward amount-based zero-order behavior. As a result, concentration changes may no longer follow the pattern expected from unsaturated clearance, making capacity limits important when interpreting measurements and planning therapy.
Evaluation centers on how circulating concentrations change over time and on estimating the contribution of removal processes such as hepatic metabolism and renal excretion. Clinicians then interpret the clearance estimate together with volume of distribution and half-life. This combined assessment provides a pharmacokinetic basis for selecting doses and recognizing whether concentration persistence may influence treatment.
Clearance estimates support different dosing decisions. Together with volume of distribution, they help inform a loading dose intended to establish treatment exposure, while clearance is central to selecting a maintenance dose that replaces ongoing removal. Half-life adds information about how quickly concentrations change. Using these measures together helps align dosing with the drug’s observed kinetic behavior.
Clearance kinetics become especially relevant when renal or hepatic impairment may reduce the body’s ability to remove a substance. They also help clinicians anticipate accumulation and recognize the potential effects of drug interactions on exposure. Applying clearance information in these situations supports individualized therapy and can reduce the risk that concentrations persist or rise beyond the intended treatment range.